Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Porphyrins are a class of heterocyclic macrocyclic organic compounds composed of four modified pyrrole subunits interconnected via methine bridges. In biological systems, they serve as essential intermediates in the biosynthesis of cofactors such as heme (iron-containing), chlorophyll (magnesium-containing), coenzyme F430 (nickel-containing), and vitamin B12 (cobalt-containing). In bacteria, endogenous porphyrins can accumulate under certain metabolic conditions or after supplementation with 5-aminolevulinic acid. These accumulated bacterial porphyrins can act as photosensitizers—when exposed to light, they generate reactive oxygen species that disrupt membrane function and lead to rapid cell death. This property is exploited in antimicrobial photodynamic therapy but also presents challenges due to potential off-target effects on host cells. "Bacterial porphyrin" is not itself a single molecular target but rather refers collectively to various naturally occurring or exogenously supplied tetrapyrrole intermediates within bacterial metabolism; thus it is not considered a canonical therapeutic target like an enzyme or receptor.[1][2][3][4] > The term "bacterial porphyrin" does not refer to a specific protein/receptor/enzyme but rather describes small-molecule metabolites involved in key cellular processes across many organisms.[3] It should not be treated as an individual druggable target. If you need structured information about specific enzymes involved in bacterial porphyrin metabolism—such as protoporphyrinogen oxidase or 5-aminolevulinic acid synthase—please specify the enzyme name for more precise data.
Generation of reactive oxygen species upon light activation leading to membrane damage and cell death in bacteria[1][2]
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Porphyrin.